GPP

Great Point Partners Portfolio holdings

AUM $240M
1-Year Est. Return 106.75%
This Quarter Est. Return
1 Year Est. Return
+106.75%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$240M
AUM Growth
+$85.7M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
38
New
Increased
Reduced
Closed

Top Buys

1
+$17.1M
2
+$15.2M
3
+$14.9M
4
APGE icon
Apogee Therapeutics
APGE
+$12.1M
5
DNTH icon
Dianthus Therapeutics
DNTH
+$10.5M

Top Sells

1
+$96.9M
2
+$27.5M
3
+$7.71M
4
AKBA icon
Akebia Therapeutics
AKBA
+$7.23M
5
EOLS icon
Evolus
EOLS
+$6.63M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMLX icon
1
Amylyx Pharmaceuticals
AMLX
$1.45B
$23.1M 9.53%
1,700,000
-300,000
RZLT icon
2
Rezolute
RZLT
$1.01B
$23M 9.5%
2,451,809
-581,653
NKTR icon
3
Nektar Therapeutics
NKTR
$1.17B
$17.1M 7.04%
+300,000
ZURA icon
4
Zura Bio
ZURA
$242M
$16.5M 6.81%
3,815,930
+645,736
SLNO icon
5
Soleno Therapeutics
SLNO
$2.69B
$15.2M 6.27%
+225,000
ASND icon
6
Ascendis Pharma
ASND
$12.3B
$14.9M 6.15%
+75,000
ABVX
7
Abivax
ABVX
$9.94B
$12.7M 5.25%
150,000
-1,141,617
APGE icon
8
Apogee Therapeutics
APGE
$5.2B
$12.1M 4.98%
+304,000
DNTH icon
9
Dianthus Therapeutics
DNTH
$1.87B
$10.5M 4.31%
+265,803
CYTK icon
10
Cytokinetics
CYTK
$7.37B
$8.24M 3.4%
150,000
IMVT icon
11
Immunovant
IMVT
$4.13B
$8.06M 3.32%
500,000
+237,824
XENE icon
12
Xenon Pharmaceuticals
XENE
$3.36B
$8.03M 3.31%
200,000
NGNE icon
13
Neurogene
NGNE
$322M
$7.74M 3.19%
446,814
-39,045
EPRX
14
Eupraxia Pharmaceuticals
EPRX
$319M
$7.08M 2.92%
+1,200,000
UPB
15
Upstream Bio Inc
UPB
$1.55B
$5.64M 2.33%
300,000
JBIO
16
Jade Biosciences
JBIO
$621M
$5.46M 2.25%
632,599
+134,545
IONS icon
17
Ionis Pharmaceuticals
IONS
$12.7B
$5.23M 2.16%
80,000
-420,000
AKRO icon
18
Akero Therapeutics
AKRO
$4.93M 2.03%
103,848
TSHA icon
19
Taysha Gene Therapies
TSHA
$1.52B
$4.91M 2.02%
1,500,000
CNTX icon
20
Context Therapeutics
CNTX
$98.3M
$4.54M 1.87%
4,683,711
PHVS icon
21
Pharvaris
PHVS
$1.54B
$3.87M 1.6%
+155,105
DBVT
22
DBV Technologies
DBVT
$803M
$3.79M 1.56%
378,594
+3,915
LEGN icon
23
Legend Biotech
LEGN
$4.31B
$3.7M 1.53%
113,460
-236,540
ORKA
24
Oruka Therapeutics
ORKA
$1.52B
$3.53M 1.45%
+183,330
UNCY icon
25
Unicycive Therapeutics
UNCY
$142M
$3.47M 1.43%
796,558
1
2